首页> 美国卫生研究院文献>Cancer Medicine >Candidate microRNAs as biomarkers of thyroid carcinoma: a systematic review meta‐analysis and experimental validation
【2h】

Candidate microRNAs as biomarkers of thyroid carcinoma: a systematic review meta‐analysis and experimental validation

机译:候选microRNA作为甲状腺癌的生物标志物:系统评价荟萃分析和实验验证

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Thyroid cancer is one of the most common carcinomas of the endocrine system with an increasing incidence. A growing number of studies have focused on the diagnostic and prognostic values of dysregulated microRNAs (miRNAs) in thyroid carcinoma. However, differences in the measurement platforms, variations in lab protocols, and small sample sizes can make gene profiling data incomparable. A meta‐review of the published studies that compared miRNA expression data of thyroid carcinoma and paired normal tissues was performed to identify potential miRNA biomarkers of thyroid carcinoma with the vote‐counting strategy. Two hundred and thirty‐six aberrantly expressed miRNAs were reported in 19 microRNA expression profiling studies. Among them, 138 miRNAs were reported in at least two studies. We also provided a meta‐signature of differentially expressed miRNAs between individual histological types of thyroid carcinoma and normal tissues. The experimental validation with qRT‐PCR analysis verified that the profiles identified with the meta‐review approach could effectively discriminate papillary thyroid carcinoma tissues from paired noncancer tissues. The meta‐review of miRNA expression profiling studies of thyroid carcinoma would provide information on candidate miRNAs that could potentially be used as biomarkers in thyroid carcinoma.
机译:甲状腺癌是内分泌系统最常见的癌症之一,发病率不断上升。越来越多的研究集中在甲状腺癌中微小RNA(miRNA)失调的诊断和预后价值上。但是,测量平台的差异,实验室规程的变化以及小样本量可能使基因谱分析数据无法比拟。对已发表的研究进行荟萃综述,比较了甲状腺癌和配对的正常组织的miRNA表达数据,以采用计票策略确定了甲状腺癌的潜在miRNA生物标记。在19个microRNA表达谱研究中报告了326个异常表达的miRNA。其中,至少两项研究报告了138个miRNA。我们还提供了在甲状腺组织学和正常组织的个别组织学类型之间差异表达的miRNA的元特征。用qRT-PCR分析进行的实验验证证明,通过meta-review方法鉴定的谱可以有效地区分甲状腺乳头状癌组织与成对的非癌组织。对甲状腺癌的miRNA表达谱研究进行的荟萃分析将提供有关可能用作甲状腺癌生物标志物的候选miRNA的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号